Flourish Research, a multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas, announced the acquisition of Diablo Clinical Research, a multi-therapeutic clinical research facility performing phase I-IV clinical trials and medical device studies.
Established in 1995, Diablo has conducted more than 1,000 trials across various therapeutic areas, establishing a strong track record in endocrinology, cardiovascular, and metabolic studies, among others. Diablo is headquartered in Walnut Creek, CA.
Reinhold Schulz, Chief Executive Officer of Flourish, said, “For 30 years, Diablo has built its reputation as a premier regional site, delivering high participant diversity, top enrollment-to-target statistics and participant retention. Diablo expands our geographic footprint and adds additional therapeutic area coverage. As a result, we can provide patients with best-in-class service and deliver to our clients accurate and timely data to support new and improved therapies.”
Emily Galdes, Chief Operating Officer of Diablo, added, “The missions of Flourish and Diablo are identical – advancing clinical research to bring life-enhancing therapies to market safely and effectively. By joining Flourish, our experienced principal investigators, management team, and staff can combine expertise that will be of great value to our sponsors and participants.”
Scott Niehaus, Managing Director at Genstar Capital, which acquired Flourish in 2024, commented, “Diablo boasts an impressive client base of sponsor and CRO partners that includes a broad range of leading pharmaceuticals, emerging biotechs and medical device companies. This is an important acquisition for Flourish given Diablo’s reputation and proximity to Silicon Valley, which provides access to expansion into new device trials and start-ups. Diablo is Flourish’s second acquisition under Genstar ownership, and we look forward to continuing to support Reinhold and the Flourish management team to grow rapidly and expand network efforts with customers.”